Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · South Carolina

AmbioPharm, Inc.

North Augusta, SC · ~184 workers · 4 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
1.1
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

AmbioPharm, Inc. runs at 32% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.

AmbioPharm, Inc.: 1.1 TCR = 32% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 4y Form 300A (see methodology below)

AmbioPharm, Inc. safety composite

AmbioPharm, Inc. scores strongest on dart rate (safer than 83% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

C

69/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
C 1.05 per 100 workers

Safer than 69% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−1.4

2018→2024

AmbioPharm, Inc. injury rate improved

AmbioPharm, Inc.'s TCR fell 1.4 from 1.4 in 2018 to 0.0 in 2024. Peak filing year was 2022 at 1.7 TCR. In 2024, DART was 0× this establishment's average TCR (severity share of cases).

2018=1.4 · 2022=1.7 · 2023=1.1 · 2024=0.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · North Augusta, SC AT/BELOW-IND · MID

Grade A · TCR 1.1 · 32% of ind

  • DART 0.0 DART
  • RANK #3/17
  • PHOTO Fenwick
  • BOOK 4y book
  • INJ 7 inj
  • SIZE ~184 FTE

Nearest TCR peer: Fenwick (0.0 TCR gap)

Read with this employer → · Industry book → · South Carolina employers → · Look up another →

AmbioPharm, Inc. in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows AmbioPharm, Inc. averages 1.1 TCR (32% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

AmbioPharm, Inc. TCR series: 2018=1.4 · 2022=1.7 · 2023=1.1 · 2024=0 · BLS 3.3

Where AmbioPharm, Inc. falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 69% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to South Carolina alone (the establishments it most directly competes with for workers and contracts): ranked #3 safest of 17 Pharmaceutical preparations (e employers in South Carolina.

AmbioPharm, Inc. (184 employees, TCR 1.1) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate AmbioPharm, Inc.
AmbioPharm, Inc. (184 employees, TCR 1.1) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

AmbioPharm, Inc. has more employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.0 0.0 0 0 0
2023 1.1 1.1 2 0 0
2022 1.7 1.1 3 0 0
2018 1.4 0.0 2 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · SC · North Augusta

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 7,610 rated employers in South Carolina with headcount on file · 46 employers in North Augusta, SC · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Fenwick 1.1 TCR
NAICS-TCR CAPS Philadelphia 1.1 TCR
NAICS-TCR BeiGene Emeryville 1.1 TCR
NAICS-TCR Janssen Pharmaceuticals Malvern 1.1 TCR
STATE-SIZE BEC - Moncks Corner Facility 184 FTE
STATE-SIZE 2948 LOWE S OF N.W. CHARLESTON SC 184 FTE
STATE-SIZE Store 1205 184 FTE
STATE-SIZE 2277 - Lexington 184 FTE
CITY-NEAR 86042B06 CVS SC DISTRIBUTION, L.L.C. 382 FTE
CITY-NEAR 1270 332 FTE
CITY-NEAR WM 1270 322 FTE
CITY-NEAR 6795-86042B0699 290 FTE
NAT-TCR Jones Contracting Corp. 1.1 TCR
NAT-TCR CompuLink-USA 1.1 TCR
NAT-TCR Pro Vision Transport 1.1 TCR
NAT-TCR 1500 Building 1.1 TCR
NAT-SIZE CDL Electric - Building Equipment Contractors 184 FTE
NAT-SIZE Napoleon Avenue 184 FTE
NAT-SIZE Piquette & Howard Electric Service, LLC 184 FTE
NAT-SIZE Schuette Metals 184 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2023, 2022, 2018. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.